| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661933 | International Journal of Cardiology | 2018 | 9 Pages |
Abstract
Based on the current meta-analysis including 17,941 ACS patients undergoing PCI, a short duration of DAPT may be safely considered, with similar rates of recurrent thrombotic complications as compared to the standard 12â¯months, and similar mortality. A more extended DAPT administration (beyond 1â¯year) provides benefits in ischemic events, but with an excess in haemorragic complications, with overall neutral effects on mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Monica Verdoia, Elvin Khedi, Claudia Ceccon, Harry Suryapranata, Giuseppe De Luca,